{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T11:47:42Z","timestamp":1789213662813,"version":"build-2803163510"},"reference-count":31,"publisher":"S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMedLife"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.25122\/jml-2025-0078","type":"journal-article","created":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T15:51:07Z","timestamp":1752076267000},"page":"463-471","source":"Crossref","is-referenced-by-count":2,"title":["PD-L1 Expression and Tumor Microenvironment Dynamics in Diffuse Large B-Cell Lymphoma: Immunophenotypic Insights"],"prefix":"10.25122","volume":"18","author":[{"given":"Georgian","family":"Halcu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Pathology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Pathology, Coltea Clinical Hospital, Bucharest, Romania","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip Cristian","family":"Mure\u0219an","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Pathology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Pathology, Bucharest Emergency University Hospital, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Niculae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Pathology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Pathology, Victor Babes National Institute for Research and Development in Pathology and Biomedical Sciences, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca","family":"Evsei-Seceleanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Pathology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Pathology, Sf. Maria Clinical Hospital, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai-Emilian","family":"Lapadat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Pathology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Pathology, Coltea Clinical Hospital, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai Adrian","family":"Cerbu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Pathology, Bucharest Emergency University Hospital, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihail","family":"Ceausu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Pathology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Pathology, C. I. Parhon National Institute of Endocrinology, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10755","reference":[{"key":"ref1","first-page":"277","article-title":"Lymphoma: Pathology, diagnosis and treatment","author":"Marcus R, Sweetenham JW, Williams ME","year":"2007","unstructured":"1. Marcus R, Sweetenham JW, Williams ME, Lymphoma: Pathology, diagnosis and treatment, Cambridge (UK):Cambridge University Press, 2007;277"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s00292-022-01132-x","article-title":"Die 5. Ausgabe der WHO-Klassifikation lymphatischer Neoplasien \u2013 ein \u00dcberblick [The 5th edition of the WHO classification of lymphoid neoplasms-an overview]","volume":"43","author":"Kurz KS, Ott G","year":"2022","unstructured":"2. Kurz KS, Ott G, Die 5. Ausgabe der WHO-Klassifikation lymphatischer Neoplasien \u2013 ein \u00dcberblick [The 5th edition of the WHO classification of lymphoid neoplasms-an overview], Pathologie (Heidelb), 2022;43(Suppl 1):64-70German","journal-title":"Pathologie (Heidelb)"},{"issue":"7","key":"ref3","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours Lymphoid Neoplasms","volume":"36","author":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, Bhagat G","year":"2022","unstructured":"3. Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, Bhagat G, The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours Lymphoid Neoplasms, Leukemia, 2022;36(7):1720-1748","journal-title":"Leukemia"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/hon.2399","article-title":"The 2016 updated WHO classification of lymphoid neoplasias","volume":"35","author":"Quintanilla-Martinez L","year":"2017","unstructured":"4. Quintanilla-Martinez L, The 2016 updated WHO classification of lymphoid neoplasias, Hematol Oncol, 2017;35(Suppl 1):37-45","journal-title":"Hematol Oncol"},{"issue":"2","key":"ref5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/s1074-7613(00)80089-8","article-title":"Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor","volume":"11","author":"Nishimura H, Nose M, Hiai H, Minato N, Honjo T","year":"1999","unstructured":"5. Nishimura H, Nose M, Hiai H, Minato N, Honjo T, Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor, Immunity, 1999;11(2):141-51","journal-title":"Immunity"},{"issue":"5","key":"ref6","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1053\/j.seminoncol.2010.09.005","article-title":"Immune checkpoint proteins: a new therapeutic paradigm for cancer--preclinical background: CTLA-4 and PD-1 blockade","volume":"37","author":"Weber J","year":"2010","unstructured":"6. Weber J, Immune checkpoint proteins: a new therapeutic paradigm for cancer--preclinical background: CTLA-4 and PD-1 blockade, Semin Oncol, 2010;37(5):430-9","journal-title":"Semin Oncol"},{"issue":"2","key":"ref7","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1517\/14728222.2014.980235","article-title":"The PD-1\/PD-L1 pathway: biological background and clinical relevance of an emerging treatment target in immunotherapy","volume":"19","author":"Muenst S, Soysal SD, Tzankov A, Hoeller S","year":"2015","unstructured":"7. Muenst S, Soysal SD, Tzankov A, Hoeller S, The PD-1\/PD-L1 pathway: biological background and clinical relevance of an emerging treatment target in immunotherapy, Expert Opin Ther Targets, 2015;19(2):201-11","journal-title":"Expert Opin Ther Targets"},{"issue":"6","key":"ref8","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1084\/jem.20031074","article-title":"Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma","volume":"198","author":"Rosenwald A, Wright G, Leroy K, Yu X, Gaulard P, Gascoyne RD","year":"2003","unstructured":"8. Rosenwald A, Wright G, Leroy K, Yu X, Gaulard P, Gascoyne RD, Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma, J Exp Med, 2003;198(6):851-62","journal-title":"J Exp Med"},{"issue":"4","key":"ref9","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1056\/NEJMoa1412082","article-title":"Nivolumab in previously untreated melanoma without BRAF mutation","volume":"372","author":"Robert C, Long GV, Brady B, Dutriaux C, Maio M, Mortier L","year":"2015","unstructured":"9. Robert C, Long GV, Brady B, Dutriaux C, Maio M, Mortier L, Nivolumab in previously untreated melanoma without BRAF mutation, N Engl J Med, 2015;372(4):320-30","journal-title":"N Engl J Med"},{"issue":"19","key":"ref10","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1182\/blood-2015-02-629600","article-title":"Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma","volume":"126","author":"Kiyasu J, Miyoshi H, Hirata A, Arakawa F, Ichikawa A, Niino D","year":"2015","unstructured":"10. Kiyasu J, Miyoshi H, Hirata A, Arakawa F, Ichikawa A, Niino D, Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma, Blood, 2015;126(19):2193-201","journal-title":"Blood"},{"issue":"1","key":"ref11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/antib11010015","article-title":"Diagnostic Performance of PD-L1 versus PD-1 Expression in Circulating CD20 Cells in Diffuse Large B-Cell Lymphoma","volume":"11","author":"Saber MM","year":"2022","unstructured":"11. Saber MM, Diagnostic Performance of PD-L1 versus PD-1 Expression in Circulating CD20 Cells in Diffuse Large B-Cell Lymphoma, Antibodies (Basel), 2022;11(1):15","journal-title":"Antibodies (Basel)"},{"issue":"1","key":"ref12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s40880-017-0262-z","article-title":"Expression and clinical value of programmed cell death-ligand 1 (PD-L1) in diffuse large B cell lymphoma: a retrospective study","volume":"36","author":"Hu LY, Xu XL, Rao HL, Chen J, Lai RC, Huang HQ","year":"2017","unstructured":"12. Hu LY, Xu XL, Rao HL, Chen J, Lai RC, Huang HQ, Expression and clinical value of programmed cell death-ligand 1 (PD-L1) in diffuse large B cell lymphoma: a retrospective study, Chin J Cancer, 2017;36(1):94","journal-title":"Chin J Cancer"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"5633096","DOI":"10.1155\/2022\/5633096","article-title":"Expression of PD-L1 and YWHAZ in Patients with Diffuse Large B Cell Lymphoma: A Possible Association with the Prognosis of Lymphoma","volume":"2022","author":"Yan S, Shang Q, Fan Z, Yang Y, Liu Y, Gao H","year":"2022","unstructured":"13. Yan S, Shang Q, Fan Z, Yang Y, Liu Y, Gao H, Expression of PD-L1 and YWHAZ in Patients with Diffuse Large B Cell Lymphoma: A Possible Association with the Prognosis of Lymphoma, J Immunol Res, 2022;20225633096","journal-title":"J Immunol Res"},{"issue":"7","key":"ref14","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1038\/s41375-019-0380-5","article-title":"Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas","volume":"33","author":"Kataoka K, Miyoshi H, Sakata S, Dobashi A, Couronn\u00e9 L, Kogure Y","year":"2019","unstructured":"14. Kataoka K, Miyoshi H, Sakata S, Dobashi A, Couronn\u00e9 L, Kogure Y, Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas, Leukemia, 2019;33(7):1687-1699","journal-title":"Leukemia"},{"issue":"4","key":"ref15","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/his.13765","article-title":"Integrative analysis of PD-L1 DNA status, mRNA status and protein status, and their clinicopathological correlation, in diffuse large B-cell lymphoma","volume":"74","author":"Sun C, Jia Y, Wang W, Bi R, Wu L, Bai Q","year":"2019","unstructured":"15. Sun C, Jia Y, Wang W, Bi R, Wu L, Bai Q, Integrative analysis of PD-L1 DNA status, mRNA status and protein status, and their clinicopathological correlation, in diffuse large B-cell lymphoma, Histopathology, 2019;74(4):618-628","journal-title":"Histopathology"},{"issue":"24","key":"ref16","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.1182\/blood-2015-12-686550","article-title":"Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas","volume":"127","author":"Georgiou K, Chen L, Berglund M, Ren W, de Miranda NF, Lisboa S","year":"2016","unstructured":"16. Georgiou K, Chen L, Berglund M, Ren W, de Miranda NF, Lisboa S, Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas, Blood, 2016;127(24):3026-34","journal-title":"Blood"},{"issue":"11","key":"ref17","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1002\/cam4.874","article-title":"PD-1 expression on the surface of peripheral blood CD4+ T cell and its association with the prognosis of patients with diffuse large B-cell lymphoma","volume":"5","author":"Zhang W, Bai JF, Zuo MX, Cao XX, Chen M, Zhang Y","year":"2016","unstructured":"17. Zhang W, Bai JF, Zuo MX, Cao XX, Chen M, Zhang Y, PD-1 expression on the surface of peripheral blood CD4+ T cell and its association with the prognosis of patients with diffuse large B-cell lymphoma, Cancer Med, 2016;5(11):3077-3084","journal-title":"Cancer Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1069378","DOI":"10.3389\/fonc.2022.1069378","article-title":"The immune checkpoint expression in the tumor immune microenvironment of DLBCL: Clinicopathologic features and prognosis","volume":"12","author":"Ma J, Pang X, Li J, Zhang W, Cui W","year":"2022","unstructured":"18. Ma J, Pang X, Li J, Zhang W, Cui W, The immune checkpoint expression in the tumor immune microenvironment of DLBCL: Clinicopathologic features and prognosis, Front Oncol, 2022;121069378","journal-title":"Front Oncol"},{"issue":"21","key":"ref19","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.18632\/oncotarget.26771","article-title":"The immune checkpoint molecules PD-1, PD-L1, TIM-3 and LAG-3 in diffuse large B-cell lymphoma","volume":"10","author":"Chen BJ, Dashnamoorthy R, Galera P, Makarenko V, Chang H, Ghosh S","year":"2019","unstructured":"19. Chen BJ, Dashnamoorthy R, Galera P, Makarenko V, Chang H, Ghosh S, The immune checkpoint molecules PD-1, PD-L1, TIM-3 and LAG-3 in diffuse large B-cell lymphoma, Oncotarget, 2019;10(21):2030-2040","journal-title":"Oncotarget"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1048567","DOI":"10.3389\/fimmu.2023.1048567","article-title":"Diffuse large B-cell lymphoma microenvironment displays a predominant macrophage infiltrate marked by a strong inflammatory signature","volume":"14","author":"Serna L, Azcoaga P, Brahmachary M, Caffarel MM, Braza MS","year":"2023","unstructured":"20. Serna L, Azcoaga P, Brahmachary M, Caffarel MM, Braza MS, Diffuse large B-cell lymphoma microenvironment displays a predominant macrophage infiltrate marked by a strong inflammatory signature, Front Immunol, 2023;141048567","journal-title":"Front Immunol"},{"issue":"1","key":"ref21","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1186\/s12885-019-6208-x","article-title":"Tumor-associated macrophages predict prognosis in diffuse large B-cell lymphoma and correlation with peripheral absolute monocyte count","volume":"19","author":"Li YL, Shi ZH, Wang X, Gu KS, Zhai ZM","year":"2019","unstructured":"21. Li YL, Shi ZH, Wang X, Gu KS, Zhai ZM, Tumor-associated macrophages predict prognosis in diffuse large B-cell lymphoma and correlation with peripheral absolute monocyte count, BMC Cancer, 2019;19(1):1049","journal-title":"BMC Cancer"},{"issue":"11","key":"ref22","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.annonc.2021.08.1991","article-title":"SPARC-positive macrophages are the superior prognostic factor in the microenvironment of diffuse large B-cell lymphoma and independent of MYC rearrangement and double-\/triple-hit status","volume":"32","author":"Croci GA, Au-Yeung RKH, Reinke S, Staiger AM, Koch K, Oschlies I","year":"2021","unstructured":"22. Croci GA, Au-Yeung RKH, Reinke S, Staiger AM, Koch K, Oschlies I, SPARC-positive macrophages are the superior prognostic factor in the microenvironment of diffuse large B-cell lymphoma and independent of MYC rearrangement and double-\/triple-hit status, Ann Oncol, 2021;32(11):1400-1409","journal-title":"Ann Oncol"},{"issue":"11","key":"ref23","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.leukres.2014.09.007","article-title":"Microvascular density, CD68 and tryptase expression in human diffuse large B-cell lymphoma","volume":"38","author":"Marinaccio C, Ingravallo G, Gaudio F, Perrone T, Nico B, Maoirano E, Specchia G, Ribatti D","year":"2014","unstructured":"23. Marinaccio C, Ingravallo G, Gaudio F, Perrone T, Nico B, Maoirano E, Specchia G, Ribatti D, Microvascular density, CD68 and tryptase expression in human diffuse large B-cell lymphoma, Leuk Res, 2014;38(11):1374-7","journal-title":"Leuk Res"},{"issue":"2","key":"ref24","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3390\/hemato2020023","article-title":"The clinical and biological effects of PD-1 expression on tumor cells in diffuse large B-cell lymphoma","volume":"2","author":"Hanamura I, Suzuki S, Ota A, Murakami S, Satou A, Takahara T","year":"2021","unstructured":"24. Hanamura I, Suzuki S, Ota A, Murakami S, Satou A, Takahara T, The clinical and biological effects of PD-1 expression on tumor cells in diffuse large B-cell lymphoma, Hemato, 2021;2(2):368-382","journal-title":"Hemato"},{"issue":"1","key":"ref25","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/cas.15179","article-title":"High PTX3 expression is associated with a poor prognosis in diffuse large B-cell lymphoma","volume":"113","author":"Carreras J, Kikuti YY, Hiraiwa S, Miyaoka M, Tomita S, Ikoma H","year":"2022","unstructured":"25. Carreras J, Kikuti YY, Hiraiwa S, Miyaoka M, Tomita S, Ikoma H, High PTX3 expression is associated with a poor prognosis in diffuse large B-cell lymphoma, Cancer Sci, 2022;113(1):334-348","journal-title":"Cancer Sci"},{"issue":"7","key":"ref26","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1182\/bloodadvances.2020003080","article-title":"Functional characterization of PD1+TIM3+ tumor-infiltrating T cells in DLBCL and effects of PD1 or TIM3 blockade","volume":"5","author":"Roussel M, Le KS, Granier C, Llamas Gutierrez F, Foucher E, Le Gallou S","year":"2021","unstructured":"26. Roussel M, Le KS, Granier C, Llamas Gutierrez F, Foucher E, Le Gallou S, Functional characterization of PD1+TIM3+ tumor-infiltrating T cells in DLBCL and effects of PD1 or TIM3 blockade, Blood Adv, 2021;5(7):1816-1829","journal-title":"Blood Adv"},{"issue":"3","key":"ref27","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1111\/jcpt.13370","article-title":"CD8+ T-cell percentage increases in diffuse large B-cell lymphoma patients receiving mannatide combined with standard regimens","volume":"46","author":"Wang M, Wang B, Fang W","year":"2021","unstructured":"27. Wang M, Wang B, Fang W, CD8+ T-cell percentage increases in diffuse large B-cell lymphoma patients receiving mannatide combined with standard regimens, J Clin Pharm Ther, 2021;46(3):832-837","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"ref28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12943-019-0977-3","article-title":"MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1\/PD-L1-mediated lymphoma cell interaction with CD8+T cells","volume":"18","author":"Zheng Z, Sun R, Zhao HJ, Fu D, Zhong HJ, Weng XQ","year":"2019","unstructured":"28. Zheng Z, Sun R, Zhao HJ, Fu D, Zhong HJ, Weng XQ, MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1\/PD-L1-mediated lymphoma cell interaction with CD8+T cells, Mol Cancer, 2019;18(1):54","journal-title":"Mol Cancer"},{"issue":"3","key":"ref29","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.21037\/apm-21-601","article-title":"The neutrophil-lymphocyte ratio and immunosuppressive acidic protein may be useful parameters for predicting depression among middle-aged patients with diffuse large B cell lymphoma","volume":"10","author":"Yi K, Lan H, Zhang Y, Liu L, Jin S, Mou X","year":"2021","unstructured":"29. Yi K, Lan H, Zhang Y, Liu L, Jin S, Mou X, The neutrophil-lymphocyte ratio and immunosuppressive acidic protein may be useful parameters for predicting depression among middle-aged patients with diffuse large B cell lymphoma, Ann Palliat Med, 2021;10(3):3299-3306","journal-title":"Ann Palliat Med"},{"issue":"4","key":"ref30","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1046\/j.1365-2141.2001.02649.x","article-title":"Prognostic significance of tumour-infiltrating T lymphocytes and T-cell subsets in de novo diffuse large B-cell lymphoma: a multiparameter flow cytometry study","volume":"112","author":"Xu Y, Kroft SH, McKenna RW, Aquino DB","year":"2001","unstructured":"30. Xu Y, Kroft SH, McKenna RW, Aquino DB, Prognostic significance of tumour-infiltrating T lymphocytes and T-cell subsets in de novo diffuse large B-cell lymphoma: a multiparameter flow cytometry study, Br J Haematol, 2001;112(4):945-9","journal-title":"Br J Haematol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"881345","DOI":"10.3389\/fgene.2022.881345","article-title":"Single-Cell RNA-Seq and Bulk RNA-Seq Reveal Intratumoral Heterogeneity and Tumor Microenvironment Characteristics in Diffuse Large B-Cell Lymphoma","volume":"13","author":"Zhao Y, Xu H, Zhang M, Li L","year":"2022","unstructured":"31. Zhao Y, Xu H, Zhang M, Li L, Single-Cell RNA-Seq and Bulk RNA-Seq Reveal Intratumoral Heterogeneity and Tumor Microenvironment Characteristics in Diffuse Large B-Cell Lymphoma, Front Genet, 2022;13881345","journal-title":"Front Genet"}],"container-title":["Journal of Medicine and Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/medandlife.org\/all-issues\/2025\/issue-5-2025\/original-article-issue-5-2025\/pd-l1-expression-and-tumor-microenvironment-dynamics-in-diffuse-large-b-cell-lymphoma-immunophenotypic-insights\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T15:51:27Z","timestamp":1752076287000},"score":1,"resource":{"primary":{"URL":"https:\/\/medandlife.org\/all-issues\/2025\/issue-5-2025\/original-article-issue-5-2025\/pd-l1-expression-and-tumor-microenvironment-dynamics-in-diffuse-large-b-cell-lymphoma-immunophenotypic-insights\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["JMedLife-18-463"],"URL":"https:\/\/doi.org\/10.25122\/jml-2025-0078","relation":{},"ISSN":["1844-3117"],"issn-type":[{"value":"1844-3117","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]}}}